Skip to content

HERZEEL: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HERZEEL

BE 0464.690.376
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€143,622
2024 · €172,364-€28,742
Equity
€1.4m
2024 · €1.3m+€98,622
Cash
€247,241
2024 · €250,461-€3,220
Balance sheet total
€1.9m
2024 · €2.0m-€135,239

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€120,868

    down €120,868 (-38.9%), from €311,081 to €190,213

    of which Other amounts receivable: -€206,522

Equity and liabilities
  • Other debts -€152,723

    down €152,723 (-44.8%), from €340,746 to €188,024

  • Profit (loss) carried forward +€98,622

    up €98,622 (+19.3%), from €511,460 to €610,082

  • Debts after one year -€71,732

    down €71,732 (-47.5%), from €151,029 to €79,297

  • Trade debts +€31,512

    up €31,512 (+40.6%), from €77,568 to €109,080

Income statement
  • Gross operating margin -€150,082

    down €150,082 (-30.0%), from €500,207 to €350,125

  • Staff costs -€79,147

    down €79,147 (-31.1%), from €254,634 to €175,487

  • Taxes -€33,029

    down €33,029 (-55.8%), from €59,156 to €26,127

  • Financial income +€6,406

    up €6,406 (+733.9%), from €873 to €7,278

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €172,364
Gross operating margin -€150,082
Staff costs +€79,147
Depreciation +€2,823
Other operating charges +€2,793
Other operating items -€2,438
Financial income +€6,406
Financial charges -€420
Taxes +€33,029
Result 2025 €143,622

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€123,649
Investment -€3,584
Financing -€123,286
Cash 2024 €250,461
Net result for the year +€143,622
Stocks and contracts +€9,389
Receivables within one year +€120,868
Deferred charges and accrued income +€5,346
Trade debts +€31,512
Tax, wage and social debts -€14,356
Advances received -€3,075
Other debts -€152,723
Accrued charges and deferred income -€16,934
Current investments -€3,584
Debts after one year -€71,732
Current portion of long-term debt -€6,554
Contributions, distributions and other -€45,000
Cash 2025 €247,241
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,000,071 €1,864,831 -€135,239 -6.8%
Fixed assets 21/28 €975,887 €975,887 = 0.0%
Financial fixed assets 28 €975,887 €975,887 = 0.0%
Current assets 29/58 €1,024,183 €888,944 -€135,239 -13.2%
Stocks and contracts in progress 3 €131,568 €122,179 -€9,389 -7.1%
Stocks 30/36 €131,568 €122,179 -€9,389 -7.1%
Amounts receivable within one year 40/41 €311,081 €190,213 -€120,868 -38.9%
Trade receivables 40 €74,770 €160,424 +€85,654 +114.6%
Other amounts receivable 41 €236,311 €29,789 -€206,522 -87.4%
Current investments 50/53 €323,663 €327,246 +€3,584 +1.1%
Cash at bank and in hand 54/58 €250,461 €247,241 -€3,220 -1.3%
Deferred charges and accrued income 490/1 €7,411 €2,065 -€5,346 -72.1%
Total equity and liabilities 10/49 €2,000,071 €1,864,831 -€135,239 -6.8%
Equity 10/15 €1,288,159 €1,386,781 +€98,622 +7.7%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €758,107 €758,107 = 0.0%
Distributable reserves 133 €758,107 €758,107 = 0.0%
Profit (loss) carried forward 14 €511,460 €610,082 +€98,622 +19.3%
Amounts payable 17/49 €711,912 €478,051 -€233,861 -32.8%
Amounts payable after more than one year 17 €151,029 €79,297 -€71,732 -47.5%
Financial debts 170/4 €151,029 €79,297 -€71,732 -47.5%
Amounts payable within one year 42/48 €543,949 €398,753 -€145,196 -26.7%
Current portion of amounts payable after more than one year 42 €84,865 €78,310 -€6,554 -7.7%
Trade debts 44 €77,568 €109,080 +€31,512 +40.6%
Suppliers 440/4 €77,568 €109,080 +€31,512 +40.6%
Advances received on contracts in progress 46 €4,010 €935 -€3,075 -76.7%
Taxes, remuneration and social security 45 €36,760 €22,404 -€14,356 -39.1%
Taxes 450/3 €15,201 €12,527 -€2,674 -17.6%
Remuneration and social security 454/9 €21,558 €9,876 -€11,682 -54.2%
Other amounts payable 47/48 €340,746 €188,024 -€152,723 -44.8%
Accrued charges and deferred income 492/3 €16,934 €0 -€16,934 -100.0%
Remuneration, social security and pensions 62 €254,634 €175,487 -€79,147 -31.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,823 €0 -€2,823 -100.0%
Other operating charges 640/8 €5,276 €2,482 -€2,793 -52.9%
Non-recurring operating charges 66A - €2,438 +€2,438
Gross operating margin 9900 €500,207 €350,125 -€150,082 -30.0%
Operating profit (loss) 9901 €237,475 €169,718 -€67,757 -28.5%
Financial income 75/76B €873 €7,278 +€6,406 +733.9%
Recurring financial income 75 €873 €7,278 +€6,406 +733.9%
Financial charges 65/66B €6,827 €7,248 +€420 +6.2%
Recurring financial charges 65 €6,827 €7,248 +€420 +6.2%
Profit (loss) for the period before taxes 9903 €231,520 €169,749 -€61,771 -26.7%
Income taxes 67/77 €59,156 €26,127 -€33,029 -55.8%
Profit (loss) for the period 9904 €172,364 €143,622 -€28,742 -16.7%
Profit (loss) for the period to be appropriated 9905 €172,364 €143,622 -€28,742 -16.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.